Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.


TSXV:KNE - Post by User

Comment by RoyMax123on Jul 20, 2023 7:09pm
71 Views
Post# 35550677

RE:RE:RE:Coactiv+ - no news, no sales update, total radio silence....

RE:RE:RE:Coactiv+ - no news, no sales update, total radio silence....I'm not sure progenacare have started working on it yet, there's no mention of coactiv+ or even Kane on their website.

The thing I'm waiting for is Dispersine clinical trial that is suppose to start this quarter (if it is not postponed again). 
Originally, they were talking to have a "big" partner with a "big" upfront payment in exchange of a % but in the last presentation they are not talking about that partnership anymore... so hopefully we'll hear what is going on about that soon.
 
On another note the piggy bank must be pretty low and looking at the SP slowly tanking I fear another low PP .
<< Previous
Bullboard Posts
Next >>